DAVIS STEPHEN has filed 43 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 17333 shares of ACADIA PHARMACEUTICALS INC ($ACAD) on August 16, 2024.
Activity breakdown: 0 open-market purchases and 15 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 16, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | A | Common Stock | 17333 | $0.00 | 173,520.0000 | 163,819,000 | 11.10% | 0.01% |
| Aug. 16, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | A | Common Stock | 44782 | $0.00 | 218,302.0000 | 163,819,000 | 25.81% | 0.03% |
| Aug. 19, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | S | Common Stock | 31747 | $15.28 | 186,555.0000 | 163,819,000 | 14.54% | 0.02% |
| May 1, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | M | Common Stock | 22391 | $0.00 | 166,658.0000 | 163,819,000 | 15.52% | 0.01% |
| May 2, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | S | Common Stock | 11427 | $16.94 | 155,231.0000 | 163,819,000 | 6.86% | 0.01% |
| May 1, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | M | Restricted Stock Units | 22391 | $0.00 | 67,173.0000 | 163,819,000 | 25.00% | 0.01% |
| April 5, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | M | Common Stock | 17333 | $0.00 | 136,175.0000 | 163,819,000 | 14.58% | 0.01% |
| April 5, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | M | Common Stock | 34666 | $0.00 | 170,841.0000 | 163,819,000 | 25.46% | 0.02% |
| April 8, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | S | Common Stock | 8858 | $17.87 | 161,983.0000 | 163,819,000 | 5.18% | 0.01% |
| April 8, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | S | Common Stock | 17716 | $17.87 | 144,267.0000 | 163,819,000 | 10.94% | 0.01% |
| April 5, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | M | Restricted Stock Units | 17333 | $0.00 | 34,667.0000 | 163,819,000 | 33.33% | 0.01% |
| April 5, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | M | Restricted Stock Units | 34666 | $0.00 | 138,666.0000 | 163,819,000 | 20.00% | 0.02% |
| March 25, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | A | Common Stock | 34666 | $0.00 | 136,556.0000 | 163,819,000 | 34.02% | 0.02% |
| March 27, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | S | Common Stock | 17714 | $17.90 | 118,842.0000 | 163,819,000 | 12.97% | 0.01% |
| March 25, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | A | Stock Option (Right to Buy) | 286451 | $0.00 | 286,451.0000 | 163,819,000 | 9999.99% | 0.17% |
| Feb. 23, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | M | Common Stock | 10946 | $0.00 | 107,467.0000 | 163,819,000 | 11.34% | 0.01% |
| Feb. 26, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | S | Common Stock | 5577 | $24.67 | 101,890.0000 | 163,819,000 | 5.19% | 0.00% |
| Feb. 23, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | M | Restricted Stock Units | 10946 | $0.00 | 10,946.0000 | 163,819,000 | 50.00% | 0.01% |
| Jan. 6, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | M | Common Stock | 9528 | $0.00 | 100,253.0000 | 163,819,000 | 10.50% | 0.01% |
| Jan. 8, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | S | Common Stock | 3732 | $29.96 | 96,521.0000 | 163,819,000 | 3.72% | 0.00% |
| Jan. 6, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | M | Restricted Stock Units | 9528 | $0.00 | 0.0000 | 163,819,000 | 100.00% | 0.01% |
| Oct. 5, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | M | Common Stock | 103999 | $0.00 | 140,694.0000 | 161,683,000 | 283.41% | 0.06% |
| Oct. 6, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | S | Common Stock | 51563 | $21.96 | 89,131.0000 | 161,683,000 | 36.65% | 0.03% |
| Oct. 6, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | M | Restricted Stock Units | 103999 | $0.00 | 173,332.0000 | 161,683,000 | 37.50% | 0.06% |
| July 14, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | M | Common Stock | 100000 | $20.77 | 136,695.0000 | 161,683,000 | 272.52% | 0.06% |
| July 14, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | S | Common Stock | 100000 | $30.04 | 36,695.0000 | 161,683,000 | 73.16% | 0.06% |
| July 14, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | M | Stock Option (Right to Buy) | 100000 | $0.00 | 220,000.0000 | 161,683,000 | 31.25% | 0.06% |
| July 11, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | S | Common Stock | 16498 | $25.00 | 91,799.0000 | 161,683,000 | 15.23% | 0.01% |
| July 12, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | S | Common Stock | 55104 | $25.05 | 36,695.0000 | 161,683,000 | 60.03% | 0.03% |
| May 1, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | A | Stock Options (Right to Buy) | 295503 | $0.00 | 295,503.0000 | 161,683,000 | 9999.99% | 0.18% |
| May 1, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | A | Restricted Stock Units | 89564 | $0.00 | 89,564.0000 | 161,683,000 | 9999.99% | 0.06% |
| April 29, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | M | Common Stock | 15625 | $0.00 | 116,103.0000 | 161,683,000 | 15.55% | 0.01% |
| May 1, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | S | Common Stock | 7806 | $21.18 | 108,297.0000 | 161,683,000 | 6.72% | 0.00% |
| April 29, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | M | Restricted Stock Units | 15625 | $0.00 | 0.0000 | 161,683,000 | 100.00% | 0.01% |
| April 5, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | M | Common Stock | 17333 | $0.00 | 109,060.0000 | 161,683,000 | 18.90% | 0.01% |
| April 6, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | S | Common Stock | 8582 | $18.16 | 100,478.0000 | 161,683,000 | 7.87% | 0.01% |
| April 5, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | M | Restricted Stock Units | 17333 | $0.00 | 52,000.0000 | 161,683,000 | 25.00% | 0.01% |
| Feb. 23, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | M | Common Stock | 10945 | $0.00 | 95,578.0000 | 161,683,000 | 12.93% | 0.01% |
| Feb. 24, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | S | Common Stock | 3851 | $18.78 | 91,727.0000 | 161,683,000 | 4.03% | 0.00% |
| Feb. 23, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | M | Restricted Stock Units | 10945 | $0.00 | 21,892.0000 | 161,683,000 | 33.33% | 0.01% |
| Jan. 6, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | M | Common Stock | 9528 | $0.00 | 88,537.0000 | 161,683,000 | 12.06% | 0.01% |
| Jan. 9, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | S | Common Stock | 3904 | $17.13 | 84,633.0000 | 161,683,000 | 4.41% | 0.00% |
| Jan. 6, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | DAVIS STEPHEN | CEO | M | Restricted Stock Units | 9528 | $0.00 | 9,528.0000 | 161,683,000 | 50.00% | 0.01% |